| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 75.25M | — |
| Operating expense | — | — |
| Net income | -194.28M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, HDP1.F returned +318.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +30.7% |
| 1 year | +318.8% |
| 5 years | +32.8% |
| 10 years | +1104.0% |
| All-time high | €75.66 (Aug 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in HDP1.F would be worth today ›No. Arrowhead Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Arrowhead Pharmaceuticals, Inc. is part of the Healthcare sector.
Arrowhead Pharmaceuticals, Inc. has a market cap of 10.69B EUR, based on the latest quote.
